Seroreversion in Subjects Receiving Antiretroviral Therapy during Acute/Early HIV Infection

Abstract
Background. We assessed human immunodeficiency virus (HIV) antibody seroreversion among individuals initiating antiretroviral therapy (ART) during acute/early HIV infection and determined whether seroreversion was associated with loss of cytotoxic T lymphocyte responses.

This publication has 33 references indexed in Scilit: